Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb Intraoperatively in Heart Transplant Patients
17.01.2024 - CytoSorb Blood Purification Results in Statistically Significant Reductions in Multiple Organ Failure and DysfunctionPRINCETON, N.J., Jan. 17, 2024 (GLOBE NEWSWIRE) - CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of ... Seite 1